0001193125-23-136025.txt : 20230504 0001193125-23-136025.hdr.sgml : 20230504 20230504164310 ACCESSION NUMBER: 0001193125-23-136025 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20230504 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DBV Technologies S.A. CENTRAL INDEX KEY: 0001613780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36697 FILM NUMBER: 23889550 BUSINESS ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 BUSINESS PHONE: 33(0)155427878 MAIL ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 8-K 1 d298404d8k.htm 8-K 8-K
00-0000000 true American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share false 0001613780 0001613780 2023-05-04 2023-05-04 0001613780 us-gaap:CommonStockMember 2023-05-04 2023-05-04 0001613780 dei:AdrMember 2023-05-04 2023-05-04

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

May 4, 2023

Date of Report (Date of earliest event reported)

 

 

DBV Technologies S.A.

(Exact name of registrant as specified in its charter)

 

 

 

France   001-36697   Not applicable

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

177-181 avenue Pierre Brossolette

92120 Montrouge France

  Not Applicable
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: +33 1 55 42 78 78

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Ordinary shares, nominal value €0.10 per share   n/a   The Nasdaq Stock Market LLC*
American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share   DBVT   The Nasdaq Stock Market LLC

 

*

Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market LLC.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition

On May 4, 2023, DBV Technologies S.A. (the “Company”) issued a press release announcing financial results and business highlights for the fiscal quarter ended March 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01

Financial Statements and Exhibits

(d)    Exhibits

 

Exhibit No.   

Description

99.1    Press Release issued May 4, 2023
104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 4, 2023   DBV TECHNOLOGIES S.A.
    By:  

/s/ Sébastien Robitaille

    Name: Sébastien Robitaille
    Title: Chief Financial Officer
EX-99.1 2 d298404dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

DBV Technologies Reports First Quarter 2023 Financial Results

 

   

DBV closes Q1 2023 with cash and cash equivalents of $192.3 million.

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the first quarter of 2023. The quarterly financial statements were approved by the Board of Directors on May 4, 2023.

Financial Highlights for the First Quarter and the Three Months Ended March 31, 2023

The Company’s unaudited consolidated financial statements for the three months ended March 31, 2023, are prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”).

Cash and cash Equivalents

 

  (in millions of USD)    Three months ended March 31,
               2023                            2022             

  Net cash & cash equivalents at the beginning of the period

   209.2   77.3

  Net increase/(decrease) in cash & cash equivalents, of which:

   (16.9)   (3.2)

  Net cash flow used in operating activities

   (20.8)   (1.5)

  Net cash flow provided by / (used in) investing activities

   -   -

  Net cash flow provided by / ((used in) financing activities

   -   (0.1)

  Effect of exchange rate changes on cash & cash equivalents

   3.9   (1.6)

  Net cash & cash equivalents at the end of the period

   192.3   74.1

Cash and cash equivalents amounted to $192.3 million as of March 31, 2023, compared to $209.2 million as of December 31, 2022, which is a net decrease of $16.9 million due to:


LOGO

 

  (1)

$20.8 million of cash used for operations, mainly driven by the impact of the initiation of the VITESSE trial in early March 2023. Cash used for operations increased by $19.3 million compared to the same quarter last year. During the first quarter of 2022, the Company received $20.9 million from French tax authorities as reimbursement of 2019 and 2020 research tax credits.

 

  (2)

Partially offset by a $3.9 million positive impact of changes in exchange rates. The Company’s treasury position, stated in US Dollars, has been impacted by an appreciation of the Euro against the US Dollar during the first quarter of 2023.

Operating Income

 

  In millions of USD    Three months ended March 31,  
             2023                    2022                    Variation          

  Research tax credits

   1.8    1.5      +0.3        +20%      

  Other operating income

   0.4    1.0      -0.6        -60%      

  Operating income

   2.2    2.5      -0.3        -12%      

Operating income amounts to $2.2 million as of March 31, 2023, compared to $2.5 million as of March 31, 2022, which is a decrease of $0.3 million due to:

 

  (1)

$0.3 million increase in the Research Tax Credit estimate as research and development costs increased during the first quarter in 2023 compared to the same quarter in 2022, mainly due to the initiation of the VITESSE trial.

 

  (2)

Offset by a $0.6 million decrease in other operating income that consists of revenues recognized in advance of the completion of the collaboration agreement with Nestlé Health Science (“NHS”).

Operating Expenses

 

  In millions of USD    Three months ended March 31,
             2023                    2022                Variation        


LOGO

 

              

  Research & Development

   16.0    12.2    +3.8    +31%

  Sales & Marketing

   0.4    0.5    -0.1    -20%

  General & Administrative

 

  

6.9

 

  

6.6

 

  

+0.3

 

  

+5%

 

  Operating expenses

   23.3    19.3    +4.0    +21%
                     

Operating expenses amounted to $23.3 million as of March 31, 2023, compared to $19.3 million as of March 31, 2022, which is an increase by $4.0 million mainly driven by research and development expenses to support initiation of the VITESSE trial.

Net Loss and Net Loss per Share

 

     Three months ended March 31,
  

2023

 

  

2022

 

  

Variation

 

  Net income / (loss) (in millions of USD)

   (20.5)    (16.7)    -3.8    -23%

  Basic / diluted net income / (loss) per share (USD/share)

   (0.22)    (0.30)    +0.1    +27%

Net result for the three months ended March 31, 2023 is a loss amounting to $20.5 million, compared to a loss amounting to $16.7 million for the same period in 2022.

On a per share basis, net loss (based on the weighted average number of shares outstanding over the period) is $0.22 for the three months ended March 31, 2023.

CONDENSED STATEMENT OF CONSOLIDATED FINANCIAL POSITION (unaudited)

 

  In millions of USD

  

March 31, 2023

 

  

December 31, 2022

 

  Assets

   232.9    246.5

  of which cash & cash equivalents

   192.3    209.2

  Liabilities

   53.8    52.1

  Shareholders’ equity

   179.1    194.5

  of which net result

   (20.5)    (96.3)


LOGO

 

CONDENSED STATEMENT OF CONSOLIDATED OPERATIONS AND COMPREHENSIVE LOSS (unaudited)

 

  In millions of USD   Three months ended March 31,
 

            2023            

 

 

            2022            

 

  Revenues

  2.2   2.5

  Research & Development

  (16.0)   (12.2)

  Sales & Marketing

  (0.4)   (0.5)

  General & Administrative

  (6.9)   (6.6)

  Restructuring income/(expenses)

  -  

  Operating expenses

  (23.3)   (19.3)

  Finance income/(expenses)

  0.6   0,2

  Income tax

  -   (0.1)
         

  Net gain/(loss)

  (20.5)   (16.7)
         

  Basic/diluted net gain/(loss) per share attributable to shareholders

  (0.22)   (0.30)


LOGO

 

CONDENSED STATEMENT OF CONSOLIDATED CASH FLOW (unaudited)

 

  In millions of USD            Three months ended March 31,        
   2023    2022
  

 

  Net cash flows provided / (used) in operating activities

   (20.8)    (1.5)

  Net cash flows provided / (used) in investing activities

   -    -

  Net cash flows provided / (used) in financing activities

   -    (0.1)

  Effect of exchange rate changes on cash & cash equivalents

   3.9    (1.6)

  Net increase / (decrease) in cash & cash equivalents

   (16.9)    (3.2)

  Net cash & cash equivalents at the beginning of the period

   209.2    77.3

 

  Net cash & cash equivalents at the end of the period

   192.3    74.1

 

About DBV Technologies

DBV Technologies is developing Viaskin, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT, and is DBV Technologies’ method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV Technologies’ food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France, and North American operations in Basking Ridge, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).

Forward Looking Statements

This press release may contain forward-looking statements and estimates, including statements regarding DBV’s financial condition and planned clinical efforts. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks


LOGO

 

and uncertainties. At this stage, DBV’s product candidates have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, including the impact of the COVID-19 pandemic, and DBV’s ability to successfully execute on its budget discipline measures. A further list and description of risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements in this press release can be found in DBV’s regulatory filings with the French Autorité des Marchés Financiers (“AMF”), DBV’s filings and reports with the U.S. Securities and Exchange Commission (“SEC”), including in DBV’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and future filings and reports made with the AMF and SEC by DBV. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release.

Investor Contact

Anne Pollak

DBV Technologies

+1 857-529-2363

anne.pollak@dbv-technologies.com

Media Contact

Angela Marcucci

DBV Technologies

+1 646-842-2393

angela.marcucci@dbv-technologies.com

Viaskin and EPIT are trademarks of DBV Technologies.

EX-101.SCH 3 dbvt-20230504.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 dbvt-20230504_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 dbvt-20230504_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country Country Region Country Region City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Title of 12(b) Security Title of 12(b) Security No Trading Symbol Flag No Trading Symbol Flag Security Exchange Name Security Exchange Name Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Information [Table] Document Information [Table] Document Information [Line Items] Document Information [Line Items] Common Stock [Member] Common Stock [Member] ADR [Member] American Depositary Share [Member] EX-101.PRE 6 dbvt-20230504_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g298404dsp_01a.jpg GRAPHIC begin 644 g298404dsp_01a.jpg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end GRAPHIC 8 g298404g0504205312799.jpg GRAPHIC begin 644 g298404g0504205312799.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
May 04, 2023
Document Information [Line Items]  
Document Type 8-K
Document Period End Date May 04, 2023
Entity Registrant Name DBV Technologies S.A.
Entity Incorporation, State or Country Code I0
Entity File Number 001-36697
Entity Tax Identification Number 00-0000000
Entity Address, Address Line One 177-181 avenue Pierre Brossolette
Entity Address, Postal Zip Code 92120
Entity Address, City or Town Montrouge
Entity Address, Country FR
Country Region 33
City Area Code 1
Local Phone Number 55 42 78 78
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001613780
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Ordinary shares, nominal value €0.10 per share
No Trading Symbol Flag true
Security Exchange Name NASDAQ
American Depositary Share [Member]  
Document Information [Line Items]  
Title of 12(b) Security American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share
Security Exchange Name NASDAQ
Trading Symbol DBVT
XML 10 d298404d8k_htm.xml IDEA: XBRL DOCUMENT 0001613780 2023-05-04 2023-05-04 0001613780 us-gaap:CommonStockMember 2023-05-04 2023-05-04 0001613780 dei:AdrMember 2023-05-04 2023-05-04 00-0000000 true American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share false 0001613780 8-K 2023-05-04 DBV Technologies S.A. I0 001-36697 177-181 avenue Pierre Brossolette 92120 Montrouge FR 33 1 55 42 78 78 false false false false Ordinary shares, nominal value €0.10 per share NASDAQ DBVT NASDAQ false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:Security12bTitle - d298404d8k.htm 7 d298404d8k.htm d298404dex991.htm dbvt-20230504.xsd dbvt-20230504_def.xml dbvt-20230504_lab.xml dbvt-20230504_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d298404d8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "dbvt-20230504_def.xml" ] }, "inline": { "local": [ "d298404d8k.htm" ] }, "labelLink": { "local": [ "dbvt-20230504_lab.xml" ] }, "presentationLink": { "local": [ "dbvt-20230504_pre.xml" ] }, "schema": { "local": [ "dbvt-20230504.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 2, "nsprefix": "dbvt", "nsuri": "http://www.dbv-technologies.com/20230504", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d298404d8k.htm", "contextRef": "duration_2023-05-04_to_2023-05-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d298404d8k.htm", "contextRef": "duration_2023-05-04_to_2023-05-04", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AdrMember": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "American Depositary Receipt (or American Depositary Share, ADS).", "label": "ADR [Member]", "terseLabel": "American Depositary Share [Member]" } } }, "localname": "AdrMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag", "terseLabel": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.dbv-technologies.com//20230504/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 18 0001193125-23-136025-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-136025-xbrl.zip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